drugset / Trial / NCT01935479
A Phase I Study of AK159 in Healthy Postmenopausal Women
RandomizedParallel-groupDouble-blindBasic science
Summary
The objective of this study is to investigate the pharmacokinetics, safety, and tolerability of AK159 administered to healthy postmenopausal women.
Timeline
- Start
- 2013-08
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MN-10-T | Unknown | — | Subcutaneous |
| Subject | Teriparatide | Protein / enzyme biologic | — | Other |